Related Experiment Video
Updated: Jun 21, 2026
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Subtypes of major depression in substance dependence
Mark J Niciu1, Grace Chan, Joel Gelernter
1Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT 06030-2103, USA.
Addiction (Abingdon, England)
|August 18, 2009
Summary
Individuals with substance dependence and both major depressive episode (MDE) subtypes show greater psychiatric severity. Differentiating MDE subtypes in substance dependence is crucial for diagnosis and treatment.
Area of Science:
- Psychiatry
- Neuroscience
- Genetics
Background:
- Substance dependence (SD) frequently co-occurs with major depressive episode (MDE).
- Understanding MDE subtypes within SD is critical for effective treatment.
- Previous research has not fully elucidated the differentiating features of MDE subtypes in SD.
Purpose of the Study:
- To evaluate features differentiating major depressive episode (MDE) subtypes in individuals with substance dependence (SD).
- To compare clinical characteristics across four groups: no MDE, independent MDE (I-MDE), substance-induced MDE (SI-MDE), and both MDE types.
Main Methods:
- Secondary data analysis of pooled data from family-based and case-control genetic studies.
- Utilized Semi-Structured Assessment for Drug Dependence and Alcoholism for data collection.
- Compared demographics, psychiatric, and substance use disorder criteria across MDE subtypes in 1929 subjects.
Main Results:
- Psychiatric measures were stronger predictors of MDE subtype than substance-related or socio-demographic factors.
- Individuals with both MDE types reported more depressive symptoms, anxiety disorders, and suicide attempts.
- Both dual MDE and I-MDE groups were more likely alcohol-dependent only compared to SI-MDE.
Conclusions:
- Substance dependence individuals with both MDE subtypes exhibit greater psychiatric severity.
- Distinct features among MDE subtypes in SD have significant diagnostic and therapeutic implications.
- Further research into these distinctions can refine clinical management strategies.
Related Concept Videos
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:30Stress and Mental Health
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...